December 6, 1996
VIA EDGAR
Securities & Exchange Commission
450 Fifth Street, NW
Washington, DC 20549
Attention: Sarah L. Cunningham
Mail Stop 3-10
Re: Pharmavene, Inc.
Ladies & Gentlemen:
On behalf of Pharmavene, Inc. (the "Company"), enclosed herewith is a
letter executed by the Company requesting withdrawl of its Registration
Statement on Form S-1 filed with the Securities & Exchange Commission on October
27, 1995 (File No. 33-98706) under the Securities Act of 1933, as amended.
If you have any questions with respect to the enclosed, please feel
free to contact the undersigned at (212) 503-2042.
Kindly acknowledge receipt of this letter and its enclosures by
stamping the enclosed copy of this letter and returning same in the stamped,
self-addressed envelope provided for your convenience.
Very truly yours,
/s/ Tina Baker
-----------------------
Tina Baker
TB/npm
Enclosures
cc: Sarah Cunningham
James D. Russo
C:\BTPM_NY_\199\0059799.01
<PAGE>
[PHARMAVENE LETTERHEAD]
November 25, 1996
Securities and Exchange Comission
450 Fifth Street, N.W.
Washington, D.C. 20549
Attention: Sarah L. Cunningham
Re: PHARMAVENE, INC.
FILE NO. 33-98706
Ladies and Gentlemen:
Pharmavene, Inc. hereby requests that its Registration Statement on
Form S-1 (File No. 33- 98706), originally filed with the Securities and Exchange
Commission pursuant to the Securities Act of 1933 on October 27, 1995, be
withdrawn due to unfavorable market conditions. Please be advised that none of
the securities for which registration was sought have been sold.
Sincerely,
/s/ James D. Russo
James D. Russo
Senior Vice President
and Chief Financial Officer
JDI/npm
cc: Mr. Jerry Crotty
The Nasdaq Stock Market
C:\BTPM_NY_\199\0059799.01
